Molecular genetics and mechanism of autosomal dominant polycystic kidney disease

被引:103
作者
Wu, GQ [1 ]
Somlo, S [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06520 USA
关键词
autosomal dominant polycystic kidney disease (ADPKD); Pkd1; Pkd2; mutations; polycystin-1; polycystin-2; knockout mice;
D O I
10.1006/mgme.1999.2943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Considerable progress toward understanding pathogenesis of autosomal dominant polycystic disease (ADPKD) has been made during the past 15 years. ADPKD is a heterogeneous human disease resulting from mutations in either of two genes, PKD1 and PKD2. The similarity in the clinical presentation and evidence of direct interaction between the COOH termini of polycystin-1 and polycystin-2, the respective gene products, suggest that both proteins act in the same molecular pathway. The fact that most mutations from ADPKD patients result in truncated polycystins as well as evidence of a loss of heterozygosity mechanism in individual PKD cysts indicate that the loss of the function of either PKD1 or PKD2 is the most likely pathogenic mechanism for ADPKD. A novel mouse model, WS25, has been generated with a targeted mutation at Phd2 locus in which a mutant exon 1 created by inserting a neo(r) cassette exists in tandem with the wild-type exon 1, This causes an unstable allele that undergoes secondary recombination to produce a true null allele at Pkd2 locus. Therefore, the model Pkd2(WS25/-), which carries the WS25 unstable allele and a true null allele, produces somatic second hits during mouse development or adult Life and establishes an extremely faithful model of human ADPKD. (C) 2000 Academic Press.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 97 条
[1]   Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells [J].
Aguiari, G ;
Manzati, E ;
Penolazzi, L ;
Micheletti, F ;
Augello, G ;
Vitali, ED ;
Cappelli, G ;
Cai, YQ ;
Reynolds, D ;
Somlo, S ;
Piva, R ;
del Senno, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (05) :880-885
[2]   A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes [J].
Ariza, M ;
Alvarez, V ;
Marin, R ;
Aguado, S ;
LopezLarrea, C ;
Alvarez, J ;
Menendez, MJ ;
Coto, E .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) :587-589
[3]   Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients [J].
Au, KS ;
Rodriguez, JA ;
Finch, JL ;
Volcik, KA ;
Roach, ES ;
Delgado, MR ;
Rodriguez, E ;
Northrup, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :286-294
[4]  
Au KS, 1997, HUM MUTAT, V9, P23, DOI 10.1002/(SICI)1098-1004(1997)9:1<23::AID-HUMU4>3.3.CO
[5]  
2-8
[6]   Mutational analysis within the 3′ region of the PKD1 gene [J].
Badenas, C ;
Torra, R ;
San Millán, JL ;
Lucero, L ;
Milà, M ;
Estivill, X ;
Darnell, A .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1225-1233
[7]   HEREDITARY POLYCYSTIC KIDNEY-DISEASE (ADULT FORM) - MICRO-DISSECTION STUDY OF 2 CASES AT AN EARLY STAGE OF DISEASE [J].
BAERT, L .
KIDNEY INTERNATIONAL, 1978, 13 (06) :519-525
[8]  
Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43913
[9]  
Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO
[10]  
2-G